サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：サイケデリック医薬品市場：薬物タイプ別、用途別、流通チャネル別、国別、地域別：産業分析、市場規模、市場シェア、2023-2030年予測
市場調査レポート
商品コード
1351417

サイケデリック医薬品市場：薬物タイプ別、用途別、流通チャネル別、国別、地域別：産業分析、市場規模、市場シェア、2023-2030年予測

Psychedelic Drugs Market, by Drug Type, By Application, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 311 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
サイケデリック医薬品市場：薬物タイプ別、用途別、流通チャネル別、国別、地域別：産業分析、市場規模、市場シェア、2023-2030年予測
出版日: 2023年08月01日
発行: AnalystView Market Insights
ページ情報: 英文 311 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

2022年のサイケデリック薬市場規模は48億7,012万米ドルで、2023年から2030年までのCAGRは13.46%で拡大。

これらの化学薬品は、潜在的な治療的・精神的用途で科学的注目を集めているが、その使用には固有のリスクが伴う。こうした危険性には、副作用や心理的な課題が含まれ、これらの物質を使用する際に個人が遭遇する可能性があります。

サイケデリック医薬品市場- 市場力学：

  • 精神衛生上の懸念に対処することの重要性に対する意識の高まり
  • 市場の成長は、都市の混雑や交通の非効率性といった課題に対処するソリューションに対する需要によって大きく形成されています。新興技術と革新的なモビリティ・ソリューションは、都市交通の景観を再定義する上で極めて重要な役割を果たしており、交通渋滞を緩和し環境への影響を低減する斬新なアプローチを提供しています。予測期間を通じて、持続可能な都市モビリティを推進する政府のイニシアティブ、官民連携、アドボカシー・キャンペーンが市場拡大の原動力になると予想されます。
  • 例えば、ここ数十年、アーバン・モビリティ財団（Urban Mobility Foundation）のような組織が、都市交通のパラダイム転換を目指したイニシアチブの先頭に立ってきました。こうした努力の結果、持続可能なモビリティが開発・採用され、より効率的で環境に優しい都市通勤が実現しました。

サイケデリック医薬品市場-セグメンテーション分析：

  • 幻覚剤の世界市場は、薬物タイプ、用途、技術、地域などを主要な分類とする包括的なセグメンテーション構造を示しています。
  • 薬物タイプの分類では、ケタミン、ガンマヒドロキシ酪酸（GHB）、リゼルグ酸ジエチルアミド（LSD）、シロシビン、3,4-メチルエネジオキシメタンフェタミン、その他様々な薬物タイプなど、多様なカテゴリーがあります。特筆すべきは、市場情勢が現在シロシビンに支配されていることです。この特定の化合物は臨床研究の最前線にあり、依存症、不安、うつ病、終末期の苦痛など、さまざまな症状の治療における潜在的効力に焦点を当てた研究が行われています。予備的な調査結果から有望な結果が明らかになり、シロシビンに基づく治療法の開発に大きな関心と資金援助が集まっています。

サイケデリック医薬品市場-競合情勢：

企業は自社製品を市場に投入するために多様な戦略を採用しており、企業ウェブサイト、オンライン小売プラットフォーム、実店舗型小売店、流通パートナー、消費者直販モデルなど、さまざまな流通チャネルを活用しています。製品メーカーは、価格戦略、製品の性能、製造技術、技術革新、ブランドの評判、製品の入手可能性など、さまざまな面で競合を繰り広げています。

市場での存在感を高め、市場シェアを拡大するために、各社はさまざまな戦術を用います。これには、新製品の発売による製品ポートフォリオの強化、流通網の拡大、研究開発投資の拡大、M&Aへの参加などが含まれます。

例えば、2022年10月、エビデンスに基づく安全なサイケデリック支援治療を推進するメンタルヘルスケア組織であるNuminus Wellness Inc.は、深刻かつ慢性的な医学的疾患のためのケタミンプログラムを発表しました。この革新的なイニシアチブは、ブリティッシュコロンビア州、ユタ州、ケベック州にあるNuminusのクリニックで最初に展開される予定であり、新しい治療手段を通じて病状に対処する先進的なアプローチを示しています。

目次

第1章 幻覚剤市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 幻覚剤の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 幻覚剤業界の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 幻覚剤市場：COVID-19感染症の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 幻覚剤市場情勢

  • サイケデリックドラッグ市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 幻覚剤市場- 薬物の種類別

  • 概要
    • 医薬品の種類別セグメントシェア分析
    • ケタミン
    • ガンマヒドロキシ酪酸（GHB）
    • リセルグ酸ジエチルアミド（LSD）
    • シロシビン
    • 3,4-メチレンジオキシメタンフェタミン
    • 他の種類の薬剤

第8章 幻覚剤市場- 用途別

  • 概要
    • アプリケーション別のセグメントシェア分析
    • アヘン中毒
    • 治療抵抗性のうつ病
    • ナルコレプシー
    • 心的外傷後ストレス障害
    • パニック障害
    • その他のアプリケーション

第9章 幻覚剤市場- 流通別

  • 概要
    • セグメントシェア分析（分布別）
    • 小売薬局
    • 病院薬局
    • オンライン流通チャネル

第10章 幻覚剤市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 幻覚剤業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Silo Wellness
    • Revive Therapeutics
    • PsyBio Therapeutics
    • Numinus Wellness
    • Mydecine Innovations Group
    • MindMed
    • MagicMed Industries
    • Field Trip Health
    • Entheon Biomedical
    • Eleusis Ltd.
    • Cybin Inc.
    • Compass Pathways
    • Bright Minds Biosciences
    • Beckley Psytech
    • Atai Life Sciences

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Psychedelic Drugs Market: Drug Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Type
  • TABLE Global Psychedelic Drugs Market, by Drug Type 2018-2030 (USD Million)
  • TABLE Psychedelic Drugs Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Psychedelic Drugs Market, by Application 2018-2030 (USD Million)
  • TABLE Psychedelic Drugs Market: Distribution Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution
  • TABLE Global Psychedelic Drugs Market, by Distribution 2018-2030 (USD Million)
  • TABLE Psychedelic Drugs Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Psychedelic Drugs Market, by Region 2018-2030 (USD Million)
  • TABLE North America Psychedelic Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Psychedelic Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE North America Psychedelic Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Psychedelic Drugs Market, by Distribution, 2018-2030 (USD Million)
  • TABLE Europe Psychedelic Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Psychedelic Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Europe Psychedelic Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Psychedelic Drugs Market, by Distribution, 2018-2030 (USD Million)
  • TABLE Asia Pacific Psychedelic Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Psychedelic Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Psychedelic Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Psychedelic Drugs Market, by Distribution, 2018-2030 (USD Million)
  • TABLE Latin America Psychedelic Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Psychedelic Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Latin America Psychedelic Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Psychedelic Drugs Market, by Distribution, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Psychedelic Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Psychedelic Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Psychedelic Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Psychedelic Drugs Market, by Distribution, 2018-2030 (USD Million)

List of Figures

  • FIGURE Psychedelic Drugs Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Drug Type segment market share analysis, 2022 & 2030
  • FIGURE Drug Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Distribution segment market share analysis, 2022 & 2030
  • FIGURE Distribution segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Psychedelic Drugs Market share and leading players, 2022
  • FIGURE Europe Psychedelic Drugs Market share and leading players, 2022
  • FIGURE Asia Pacific Psychedelic Drugs Market share and leading players, 2022
  • FIGURE Latin America Psychedelic Drugs Market share and leading players, 2022
  • FIGURE Middle East and Africa Psychedelic Drugs Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Psychedelic Drugs Market share analysis by country, 2022
  • FIGURE Germany Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Psychedelic Drugs Market share analysis by country, 2022
  • FIGURE India Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Psychedelic Drugs Market share analysis by country, 2022
  • FIGURE Brazil Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Psychedelic Drugs Market share analysis by country, 2022
  • FIGURE Saudi Arabia Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1666

REPORT HIGHLIGHT

Psychedelic Drugs Market size was valued at USD 4,870.12 Million in 2022, expanding at a CAGR of 13.46% from 2023 to 2030.

Substances categorized as "psychedelics" possess the capacity to induce profound alterations in perception, cognitive processes, and emotional states, often leading to intense sensory encounters and potentially life-altering insights. This category includes substances like psilocybin mushrooms, DMT (dimethyltryptamine), and LSD (lysergic acid diethylamide). These compounds exert their effects by targeting specific receptors in the brain, resulting in hallucinogenic phenomena, heightened emotional responses, and shifts in consciousness.

While these chemical agents have garnered scientific attention for their potential therapeutic and spiritual applications, their usage carries inherent risks. These hazards encompass adverse side effects and psychological challenges that individuals may encounter when engaging with these substances.

Psychedelic Drugs Market - Market Dynamics:

  • Increasing awareness about the importance of addressing mental health concerns
  • The growth of the market is significantly shaped by the demand for solutions addressing the challenges of urban congestion and transportation inefficiencies. Emerging technologies and innovative mobility solutions are playing a pivotal role in redefining urban transportation landscapes, offering novel approaches to alleviate traffic congestion and reduce environmental impact. Throughout the forecasted period, it is anticipated that government initiatives, public-private collaborations, and advocacy campaigns promoting sustainable urban mobility will drive market expansion.
  • For example, in recent decades, organizations like the Urban Mobility Foundation have spearheaded initiatives aimed at transforming urban transportation paradigms. Their efforts have resulted in the development and adoption of sustainable mobility practices, contributing to more efficient and eco-friendly urban commuting options.

Psychedelic Drugs Market - Key Insights:

  • As per the insights provided by our research analysts, the global Market for Psychedelic Drugs is poised to experience a robust annual growth rate, with a projected Compound Annual Growth Rate (CAGR) of approximately 14.2% throughout the forecast period spanning from 2023 to 2030.
  • This industry's growth trajectory is underpinned by significant factors, primarily the increasing recognition of the critical need to address mental health challenges on a global scale.
  • Within the realm of drug categorization, the segment dedicated to psilocybin emerged as the dominant player in terms of market share for the year 2022.
  • Furthermore, when considering application segmentation, the category related to the treatment of resistant depression stood out as the frontrunner in 2022.
  • Examining distribution channels, hospitals took the lead in 2022 in terms of market presence.
  • In geographical terms, North America emerged as the primary revenue contributor in the year 2022.

Psychedelic Drugs Market- Segmentation Analysis:

  • The Global Market for Psychedelic Drugs exhibits a comprehensive segmentation structure, incorporating Drug Type, Application, Technology, and Geographical Region as its key categorizations.
  • Within the spectrum of Drug Type classification, the market presents a diverse array of categories, including Ketamine, Gamma Hydroxybutyric Acid (GHB), Lysergic Acid Diethylamide (LSD), Psilocybin, 3,4-MethylEnedioxyMethamphetamine, and various other drug types. Notably, the market's landscape is currently dominated by Psilocybin. This particular compound has been at the forefront of clinical investigations, with studies focusing on its potential efficacy in treating a spectrum of conditions such as addiction, anxiety, depression, and end-of-life distress. The preliminary research findings have unveiled promising outcomes, prompting considerable interest and financial support for the development of treatment modalities based on Psilocybin.

Psychedelic Drugs Market- Competitive Landscape:

Enterprises employ diverse strategies to bring their products to market, utilizing an array of distribution channels such as corporate websites, online retail platforms, brick-and-mortar retailers, distribution partners, and direct-to-consumer models. Product manufacturers engage in competition across multiple fronts, including pricing strategies, product performance, manufacturing techniques, technological innovation, brand reputation, and product availability.

To fortify their market presence and expand their market share, companies employ a range of tactics. These include product portfolio enhancements through new product launches, the expansion of distribution networks, increased investments in research and development, and participation in mergers and acquisitions.

For instance, in October 2022, Numinus Wellness Inc., a mental health care organization dedicated to advancing evidence-based, safe psychedelic-assisted treatments, introduced its Ketamine for Serious and Chronic Medical Illness Program. This innovative initiative is expected to roll out initially in Numinus clinics located in British Columbia, Utah, and Quebec, signifying a progressive approach to addressing medical conditions through novel therapeutic avenues.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PSYCHEDELIC DRUGS MARKET KEY PLAYERS

  • Silo Wellness
  • Revive Therapeutics
  • PsyBio Therapeutics
  • Numinus Wellness
  • Mydecine Innovations Group
  • MindMed
  • MagicMed Industries
  • Field Trip Health
  • Entheon Biomedical
  • Eleusis Ltd.
  • Cybin Inc.
  • Compass Pathways
  • Bright Minds Biosciences
  • Beckley Psytech
  • Atai Life Sciences

GLOBAL PSYCHEDELIC DRUGS MARKET, BY DRUG TYPE

  • Ketamine
  • Gamma Hydroxybutyric Acid (GHB)
  • Lysergic Acid Diethylamide (LSD)
  • Psilocybin
  • 3,4-MethylEnedioxyMethamphetamine
  • Other Drug Types

GLOBAL PSYCHEDELIC DRUGS MARKET, BY APPLICATION

  • Opiate Addiction
  • Treatment-Resistant Depression
  • Narcolepsy
  • Post-traumatic Stress Disorder
  • Panic Disorder
  • Others Applications

GLOBAL PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Distribution Channel

GLOBAL PSYCHEDELIC DRUGS MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. Psychedelic Drugs Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Psychedelic Drugs Market Snippet by Drug Type
    • 2.1.2. Psychedelic Drugs Market Snippet by Application
    • 2.1.3. Psychedelic Drugs Market Snippet by Distribution
    • 2.1.4. Psychedelic Drugs Market Snippet by Country
    • 2.1.5. Psychedelic Drugs Market Snippet by Region
  • 2.2. Competitive Insights

3. Psychedelic Drugs Key Market Trends

  • 3.1. Psychedelic Drugs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Psychedelic Drugs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Psychedelic Drugs Market Opportunities
  • 3.4. Psychedelic Drugs Market Future Trends

4. Psychedelic Drugs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Psychedelic Drugs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Psychedelic Drugs Market Landscape

  • 6.1. Psychedelic Drugs Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Psychedelic Drugs Market - By Drug Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug Type, 2022 & 2030 (%)
    • 7.1.2. Ketamine
    • 7.1.3. Gamma Hydroxybutyric Acid (GHB)
    • 7.1.4. Lysergic Acid Diethylamide (LSD)
    • 7.1.5. Psilocybin
    • 7.1.6. 3,4-MethylEnedioxyMethamphetamine
    • 7.1.7. Other Drug Types

8. Psychedelic Drugs Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Opiate Addiction
    • 8.1.3. Treatment-Resistant Depression
    • 8.1.4. Narcolepsy
    • 8.1.5. Post-traumatic Stress Disorder
    • 8.1.6. Panic Disorder
    • 8.1.7. Others Applications

9. Psychedelic Drugs Market - By Distribution

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution, 2022 & 2030 (%)
    • 9.1.2. Retail Pharmacy
    • 9.1.3. Hospital Pharmacy
    • 9.1.4. Online Distribution Channel

10. Psychedelic Drugs Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Psychedelic Drugs Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Psychedelic Drugs Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Psychedelic Drugs Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Psychedelic Drugs Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Psychedelic Drugs Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Psychedelic Drugs Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Silo Wellness
    • 11.2.2. Revive Therapeutics
    • 11.2.3. PsyBio Therapeutics
    • 11.2.4. Numinus Wellness
    • 11.2.5. Mydecine Innovations Group
    • 11.2.6. MindMed
    • 11.2.7. MagicMed Industries
    • 11.2.8. Field Trip Health
    • 11.2.9. Entheon Biomedical
    • 11.2.10. Eleusis Ltd.
    • 11.2.11. Cybin Inc.
    • 11.2.12. Compass Pathways
    • 11.2.13. Bright Minds Biosciences
    • 11.2.14. Beckley Psytech
    • 11.2.15. Atai Life Sciences

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us